From April 1, 2023 to June 30, 2023, the company has repurchased 6,482,035 shares, representing 1.12% for CNY 122.21 million. With this, the company has completed the repurchase of 9,835,793 shares, representing 1.7% for CNY 199.51 million under the buyback announced on October 21, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.15 CNY | +2.08% | +2.81% | +3.07% |
Apr. 26 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.07% | 1.6B | |
-4.57% | 12.45B | |
-3.17% | 8.22B | |
+6.16% | 5.72B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-6.11% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.